Table 1. Mapped HPV-16 CD8 T cell... | Rockefeller University Press

Table 1.

Mapped HPV-16 CD8⁺ T cell epitopes

Antigen	Epitope	HLA restriction	Number of +ve patients	Number of patients with HLA
HPV-16-E1	FELSQMVQW	B*18:01	1	5
	FELSQMVQW	B*44:02	1	24
	TLLQQYCLYL^a	A*02:01	2	34
	SEIAYKYAQL	B*18:01	1	5
	SEIAYKYAQL	B*44:02	1	24
	RPFKSNKST	B*07:02	1	17
	ALDGNLVSMDV	A*02:01	1	34
	YLHNRLVVF	B*08:01	2	14
	SRWPYLHNR	B*27:05	1	6
HPV-16-E2	TLQDVSLEVYL^a	A*02:01	3	34
	YICEEASVTVV^a	A*02:01	1	34
	NKVWEVHAGGQVILC	A*01:01	2	24
	HRDSVDSAPI	B*27:05	3	6
	YVHEGIRTY^a	B*35:01	1	6
	QVDYYGLYY	A*01:01	1	24
	HPAATHTKAV^a	B*07:02	2	17
HPV-16-E4	WPTTPPRPI	B*07:02	1	17
HPV-16-E5	NLDTASTTL	C*05:01	5	21
	NLDTASTTL	C*08:02	2	3
	SAFRCFIVY^a	B*35:01	1	6
	SAFRCFIVY^a	B*35:43	1	1
HPV-16-E6	HDIILECVY^a	B*18:01	2	5
	TIHDIILECV^a	A*02:01	1	34
	AFRDLCIVY^a	C*07:02	3	19
	GRWTGRCMSC^a	B*27:05	4	6
HPV-16-E7	LEDLLMGTLGI^a	C*04:01	2	9
HPV-16-E7	HVDIRTLEDLLMGTL^a	A*02:01	1	34

Antigen	Epitope	HLA restriction	Number of +ve patients	Number of patients with HLA
HPV-16-E1	FELSQMVQW	B*18:01	1	5
	FELSQMVQW	B*44:02	1	24
	TLLQQYCLYLa	A*02:01	2	34
	SEIAYKYAQL	B*18:01	1	5
	SEIAYKYAQL	B*44:02	1	24
	RPFKSNKST	B*07:02	1	17
	ALDGNLVSMDV	A*02:01	1	34
	YLHNRLVVF	B*08:01	2	14
	SRWPYLHNR	B*27:05	1	6
HPV-16-E2	TLQDVSLEVYLa	A*02:01	3	34
	YICEEASVTVVa	A*02:01	1	34
	NKVWEVHAGGQVILC	A*01:01	2	24
	HRDSVDSAPI	B*27:05	3	6
	YVHEGIRTYa	B*35:01	1	6
	QVDYYGLYY	A*01:01	1	24
	HPAATHTKAVa	B*07:02	2	17
HPV-16-E4	WPTTPPRPI	B*07:02	1	17
HPV-16-E5	NLDTASTTL	C*05:01	5	21
	NLDTASTTL	C*08:02	2	3
	SAFRCFIVYa	B*35:01	1	6
	SAFRCFIVYa	B*35:43	1	1
HPV-16-E6	HDIILECVYa	B*18:01	2	5
	TIHDIILECVa	A*02:01	1	34
	AFRDLCIVYa	C*07:02	3	19
	GRWTGRCMSCa	B*27:05	4	6
HPV-16-E7	LEDLLMGTLGIa	C*04:01	2	9
HPV-16-E7	HVDIRTLEDLLMGTLa	A*02:01	1	34

Previously published epitope sequences.

Sharing Unavailable